Search hospitals

>

Florida

>

Jacksonville

Mayo Clinic in Florida

Claim this profile

Jacksonville, Florida 32224

Global Leader in Breast Cancer

Global Leader in Cancer

Conducts research for Lung Cancer

Conducts research for Pancreatic Cancer

Conducts research for Solid Tumors

1617 reported clinical trials

139 medical researchers

Photo of Mayo Clinic in Florida in JacksonvillePhoto of Mayo Clinic in Florida in JacksonvillePhoto of Mayo Clinic in Florida in Jacksonville

Summary

Mayo Clinic in Florida is a medical facility located in Jacksonville, Florida. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Pancreatic Cancer, Solid Tumors and other specialties. Mayo Clinic in Florida is involved with conducting 1,617 clinical trials across 1,489 conditions. There are 139 research doctors associated with this hospital, such as Steven Attia, MD, Sikander Ailawadhi, Mahesh Seetharam, and Amit Mahipal, MD.

Area of expertise

1

Breast Cancer

Global Leader

Mayo Clinic in Florida has run 199 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
Stage III
ER positive
2

Cancer

Global Leader

Mayo Clinic in Florida has run 191 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at Mayo Clinic in Florida

Breast Cancer

Skin Cancer

Lung Cancer

Esophageal cancer

Cervical Cancer

Cancer

Liver Cancer

Breast cancer

Multiple Myeloma

Cutaneous Melanoma

Image of trial facility.

Cancer Vaccine + Pembrolizumab

for Advanced Cancers

This phase I trial tests the safety and tolerability of an experimental personalized vaccine when given by itself and with pembrolizumab in treating patients with solid tumor cancers that have spread to other places in the body (advanced). The experimental vaccine is designed target certain proteins (neoantigens) on individuals' tumor cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving the personalized neoantigen peptide-based vaccine with pembrolizumab may be safe and effective in treating patients with advanced solid tumors.

Recruiting

3 awards

Phase 1 & 2

50 criteria

Image of trial facility.

Elacestrant

for Breast Cancer

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.

Recruiting

2 awards

Phase 3

3 criteria

Image of trial facility.

Sacituzumab Govitecan + Pembrolizumab

for Triple Negative Breast Cancer

The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.

Recruiting

2 awards

Phase 3

6 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Mayo Clinic in Florida?

Where is Mayo Clinic in Florida located?

Who should I call to ask about financial aid or insurance network?

What insurance does Mayo Clinic in Florida accept?

What awards or recognition has Mayo Clinic in Florida received?